‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19. By mimicking the receptor that the virus binds to rather than targeting the virus itself, nanodecoy therapy could remain effective against emerging variants of the virus. 

Inhalation Therapy Shows Promise Against Pulmonary Fibrosis in Mice, Rats

A new study from North Carolina State University shows that lung stem cell secretions – specifically exosomes and secretomes – delivered via nebulizer, can help repair lung injuries due to multiple types of pulmonary fibrosis in mice and rats. The work could lead to more effective, less invasive treatment for human pulmonary fibrosis sufferers. 

Scientists Create Stem Cell Therapy For Lung Fibrosis Conditions

A joint UNC School of Medicine-NC State research project shows how to harvest lung stem cells non-invasively and then multiply healthy cells - a potential powerful therapy against inflammatory lung conditions. 

Spheroid Stem Cell Production Sows Hope For IPF Treatment

In a small pilot study, researchers from North Carolina State University have demonstrated a rapid, simple way to generate large numbers of lung stem cells for use in disease treatment. 

Feb. 26-27, 2019

CED Life Science Conference 2019

Raleigh Convention Center

Raleigh, NC

May 17-22, 2019

American Thoracic Society International Conference 2019

Kay Bailey Hutchison Convention Center

Dallas, TX